Arash Soltani

1.8k total citations
32 papers, 1.3k citations indexed

About

Arash Soltani is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Arash Soltani has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Immunology and 7 papers in Oncology. Recurrent topics in Arash Soltani's work include Immune Cell Function and Interaction (5 papers), T-cell and Retrovirus Studies (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Arash Soltani is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and Retrovirus Studies (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Arash Soltani collaborates with scholars based in Iran, United States and Australia. Arash Soltani's co-authors include Seyed Isaac Hashemy, Amir R. Afshari, Atefeh Ghahremanloo, Amirhossein Sahebkar, Mostafa Karimi Roshan, Kiarash Ghazvini, Anvar Soleimani, Neda Yaghoubi, Mohammad Soukhtanloo and Hossein Javid and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular Physiology and Journal of Cellular Biochemistry.

In The Last Decade

Arash Soltani

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arash Soltani Iran 18 539 451 332 227 155 32 1.3k
Heriberto Prado-Garcı́a Mexico 19 757 1.4× 405 0.9× 355 1.1× 445 2.0× 200 1.3× 47 1.5k
Zahra Asadzadeh Iran 23 668 1.2× 573 1.3× 458 1.4× 320 1.4× 140 0.9× 45 1.7k
Elizabeth Ortíz-Sánchez Mexico 19 596 1.1× 471 1.0× 173 0.5× 253 1.1× 133 0.9× 41 1.2k
Gabriella Emri Hungary 23 521 1.0× 388 0.9× 219 0.7× 151 0.7× 111 0.7× 71 1.2k
Ranjini K. Sundaram United States 20 557 1.0× 369 0.8× 274 0.8× 165 0.7× 111 0.7× 45 1.4k
José Sullivan López-González Mexico 19 793 1.5× 370 0.8× 338 1.0× 382 1.7× 144 0.9× 45 1.6k
Armel Hervé Nwabo Kamdje Cameroon 19 685 1.3× 349 0.8× 160 0.5× 268 1.2× 144 0.9× 46 1.4k
Zhe Liu China 20 659 1.2× 321 0.7× 148 0.4× 328 1.4× 121 0.8× 53 1.2k
Yi Lü United States 23 933 1.7× 349 0.8× 154 0.5× 260 1.1× 124 0.8× 68 1.6k

Countries citing papers authored by Arash Soltani

Since Specialization
Citations

This map shows the geographic impact of Arash Soltani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Soltani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Soltani more than expected).

Fields of papers citing papers by Arash Soltani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Soltani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Soltani. The network helps show where Arash Soltani may publish in the future.

Co-authorship network of co-authors of Arash Soltani

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Soltani. A scholar is included among the top collaborators of Arash Soltani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Soltani. Arash Soltani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barzegar, Mohsen, et al.. (2024). Utilizing pistachio green hull extract to produce sugar-free muffins with antioxidant and antidiabetic potential. Applied Food Research. 4(2). 100510–100510. 5 indexed citations
2.
Nejatian, Mohammad, et al.. (2024). Application of Spirulina as an innovative ingredient in pasta and bakery products. Food Bioscience. 62. 105170–105170. 4 indexed citations
3.
Jalili‐Nik, Mohammad, Arash Soltani, Seyed Isaac Hashemy, et al.. (2023). Development of Potential Inhibitors for Human T-lymphotropic VirusType I Integrase Enzyme: A Molecular Modeling Approach. Current Computer - Aided Drug Design. 20(1). 72–86. 1 indexed citations
4.
Jalili‐Nik, Mohammad, Arash Soltani, Amir R. Afshari, et al.. (2023). Rigosertib is more potent than wortmannin and rapamycin against adult T‐cell leukemia‐lymphoma. BioFactors. 49(6). 1174–1188. 2 indexed citations
5.
Soltani, Arash, et al.. (2022). Thymol has anticancer effects in U-87 human malignant glioblastoma cells. Molecular Biology Reports. 49(10). 9623–9632. 22 indexed citations
6.
Afshari, Amir R., Arash Soltani, Hossein Javid, et al.. (2021). Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme. Current Medicinal Chemistry. 28(24). 4877–4892. 24 indexed citations
7.
Soltani, Arash, et al.. (2021). Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer. Molecular Biology Reports. 48(5). 4797–4811. 27 indexed citations
8.
Jalili‐Nik, Mohammad, Arash Soltani, Baratali Mashkani, Houshang Rafatpanah, & Seyed Isaac Hashemy. (2021). PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma. International Immunopharmacology. 98. 107870–107870. 26 indexed citations
9.
Afshari, Amir R., Hamid Mollazadeh, Elmira Mohtashami, et al.. (2020). Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway. Current Medicinal Chemistry. 28(2). 377–400. 34 indexed citations
10.
Ghahremanloo, Atefeh, et al.. (2020). Cytokines as potential combination agents with PD‐1/PD‐L1 blockade for cancer treatment. Journal of Cellular Physiology. 235(7-8). 5449–5460. 48 indexed citations
11.
Ghahremanloo, Atefeh, Arash Soltani, Seyed Mohamad Sadegh Modaresi, & Seyed Isaac Hashemy. (2019). Recent advances in the clinical development of immune checkpoint blockade therapy. Cellular Oncology. 42(5). 609–626. 80 indexed citations
12.
Roshan, Mostafa Karimi, Arash Soltani, Anvar Soleimani, et al.. (2019). Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochimie. 165. 229–234. 190 indexed citations
13.
Salmaninejad, Arash, Saeed Farajzadeh Valilou, Arash Soltani, et al.. (2019). Tumor-associated macrophages: role in cancer development and therapeutic implications. Cellular Oncology. 42(5). 591–608. 174 indexed citations
14.
Javid, Hossein, et al.. (2019). Emerging roles of microRNAs in regulating the mTOR signaling pathway during tumorigenesis. Journal of Cellular Biochemistry. 120(7). 10874–10883. 15 indexed citations
15.
Yaghoubi, Neda, et al.. (2018). PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer. Biomedicine & Pharmacotherapy. 110. 312–318. 205 indexed citations
16.
Soltani, Arash, Seyed Isaac Hashemy, Farnaz Zahedi Avval, et al.. (2018). Molecular targeting for treatment of human T-lymphotropic virus type 1 infection. Biomedicine & Pharmacotherapy. 109. 770–778. 27 indexed citations
17.
Ebrahimi, Safieh, Arash Soltani, & Seyed Isaac Hashemy. (2018). Oxidative stress in cervical cancer pathogenesis and resistance to therapy. Journal of Cellular Biochemistry. 120(5). 6868–6877. 39 indexed citations
18.
Soltani, Arash, Arash Salmaninejad, Mohammad Jalili‐Nik, et al.. (2018). 5′‐Adenosine monophosphate‐activated protein kinase: A potential target for disease prevention by curcumin. Journal of Cellular Physiology. 234(3). 2241–2251. 27 indexed citations
19.
Soleimani, Anvar, Amirhossein Bahreyni, Mostafa Karimi Roshan, et al.. (2018). Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives. Journal of Cellular Physiology. 234(3). 2329–2336. 23 indexed citations
20.
Soltani, Arash, Amirhossein Bahreyni, Nadia Boroumand, et al.. (2017). Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives. Journal of Cellular Physiology. 233(6). 4783–4790. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heriberto Prado-Garcı́a Breakdown of academic impact, for papers by Zahra Asadzadeh Breakdown of academic impact, for papers by Elizabeth Ortíz-Sánchez Breakdown of academic impact, for papers by Gabriella Emri Breakdown of academic impact, for papers by Ranjini K. Sundaram Breakdown of academic impact, for papers by José Sullivan López-González Breakdown of academic impact, for papers by Armel Hervé Nwabo Kamdje Breakdown of academic impact, for papers by Zhe Liu Breakdown of academic impact, for papers by Yi Lü
Rankless by CCL
2026